FDA Import Refusal 799-7042385-0/11/1 — Merck Kommanditgesellschaft Auf Aktien
The FDA refused shipment 799-7042385-0/11/1 from Merck Kommanditgesellschaft Auf Aktien (Germany) on Feb 6, 2022. The refused product falls under Drugs and Biologics — CETRORELIX ACETATE (GONAD-STIMULATING PRINCIPLE). Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal details
- Date
- Feb 6, 2022
- Country
- Germany
- Product Category
- Drugs and Biologics
- Product Code
- 64MCY13 CETRORELIX ACETATE (GONAD-STIMULATING PRINCIPLE)
- Charges
- 75